Singapore, July 28 -- Harbour BioMed, a US-based biopharmaceutical company, has entered into a strategic collaboration with China National Pharmaceutical Group (Sinopharm). The two parties will establish the Sinopharm - Harbour BioMed Innovation Consortium to advance collaborative research and development of innovative biologics.

Published by HT Digital Content Services with permission from BioSpectrum Asia....